News Briefs

A case before the U.S. Supreme Court, which will determine how far states can go in regulating PBMs, will be delayed due to the COVID-19 crisis. Oral arguments in Rutledge v. Pharmaceutical Care Management Association were scheduled for April 27 but have now been postponed to an unspecified date. The case, which challenges a 2015 law enacted in Arkansas, concerns whether PBMs are acting as agents under the Employee Retirement Income Security Act of 1974 (ERISA) and therefore are exempt from state-level regulation. Read more at https://bit.ly/2Rmyuyd.

Before oral arguments were rescheduled for Rutledge v. Pharmaceutical Care Management Association, America’s Health Insurance Plans (AHIP) filed an amicus brief supporting PCMA — the PBM trade group that is one of the parties in the case. AHIP said its brief focuses on the importance and need for the uniform administration of employer sponsored plans under ERISA” and “details the negative effects laws like the one passed in Arkansas have on the design and uniform administration of employer sponsored plan benefits, and why they are preempted by ERISA.” Read the brief at https://bit.ly/34kjNAY.

© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/09/Drug_Benefits_Life_Sciences.jpg
November 23

Will ‘Build Back Better’ Spell Disaster for Pharma Innovation?

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-health-plan-weekly-Wall-Street-Isnt-Sweating-Cignas-Third-Quarter-MLR-Miss.jpg
November 23

Big Three PBMs’ 3Q Results Make Up for Insurer Disappointments

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_442155384.jpg
November 23

SCAN Health Opts to Invest in Medication Adherence Tool

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today